Mid-term outcome of magnetic resonance-guided focused ultrasound surgery for uterine myomas: From six to twelve months after volume reduction

At present, type 3 myomas should be exempted from the application of MRgFUS, because the nonperfused ratio immediately after the procedure was small compared with that in type 1 and type 2 myomas, and the subsequent volume change was unfavorable.